Management of Pancreatic Neuroendocrine Tumors

被引:20
作者
Dickson, Paxton V. [1 ]
Behrman, Stephen W. [1 ]
机构
[1] Univ Tennessee, Hlth Sci Ctr, Dept Surg, Div Surg Oncol, Memphis, TN 38163 USA
关键词
Pancreatic neuroendocrine tumors; Surgery; Metastatic neuroendocrine tumors; Chemotherapy; Targeted therapy; HEPATIC ARTERIAL CHEMOEMBOLIZATION; LONG-TERM SURVIVAL; ENDOCRINE TUMORS; SURGICAL-TREATMENT; LIVER METASTASES; CHROMOGRANIN-A; PHASE-II; RADIOFREQUENCY ABLATION; CONSENSUS GUIDELINES; LOW-GRADE;
D O I
10.1016/j.suc.2013.02.001
中图分类号
R61 [外科手术学];
学科分类号
摘要
Pancreatic neuroendocrine tumors account for 1% to 2% of pancreatic neoplasms and may occur sporadically or as part of a hereditary syndrome. Patients may present with symptoms related to hormone secretion by functional tumors or to locally advanced or metastatic nonfunctional tumors. Asymptomatic pancreatic neuroendocrine tumors are increasingly detected incidentally during abdominal imaging performed for other reasons. The management of localized pancreatic neuroendocrine tumors is surgical resection. Hepatic metastases are common and their management involves a variety of liver-directed therapies, which should be tailored according to extent of disease, symptoms, presence of extrahepatic metastases, and patient performance status.
引用
收藏
页码:675 / +
页数:18
相关论文
共 101 条
[71]   Neuroendocrine neoplasms of the gut and pancreas: new insights [J].
Rindi, Guido ;
Wiedenmann, Bertram .
NATURE REVIEWS ENDOCRINOLOGY, 2012, 8 (01) :54-64
[72]   Placebo-Controlled, Double-Blind, Prospective, Randomized Study on the Effect of Octreotide LAR in the Control of Tumor Growth in Patients With Metastatic Neuroendocrine Midgut Tumors: A Report From the PROMID Study Group [J].
Rinke, Anja ;
Mueller, Hans-Helge ;
Schade-Brittinger, Carmen ;
Klose, Klaus-Jochen ;
Barth, Peter ;
Wied, Matthias ;
Mayer, Christina ;
Aminossadati, Behnaz ;
Pape, Ulrich-Frank ;
Blaeker, Michael ;
Harder, Jan ;
Arnold, Christian ;
Gress, Thomas ;
Arnold, Rudolf .
JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (28) :4656-4663
[73]   Imaging of neuroendocrine tumours (CT/MR/US) [J].
Rockall, Andrea G. ;
Reznek, Rodney H. .
BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM, 2007, 21 (01) :43-68
[74]   Ki67, E-cadherin, and p53 as prognostic indicators of long-term outcome after liver transplantation for metastatic neuroendocrine tumors [J].
Rosenau, J ;
Bahr, MJ ;
von Wasielewski, R ;
Mengel, M ;
Schmidt, HHJ ;
Nashan, B ;
Lang, H ;
Klempnauer, J ;
Manns, MP ;
Boeker, KHW .
TRANSPLANTATION, 2002, 73 (03) :386-394
[75]  
RUSZNIEWSKI P, 1993, CANCER, V71, P2624, DOI 10.1002/1097-0142(19930415)71:8<2624::AID-CNCR2820710830>3.0.CO
[76]  
2-B
[77]   Hepatic arterial chemoembolization in the management of advanced digestive endocrine tumors [J].
Ruszniewski, P ;
Malka, D .
DIGESTION, 2000, 62 :79-83
[78]   Surgical treatment of neuroendocrine metastases to the liver: A plea for resection to increase survival [J].
Sarmiento, JM ;
Heywood, G ;
Rubin, J ;
Ilstrup, DM ;
Nagorney, DM ;
Que, FG .
JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2003, 197 (01) :29-37
[79]  
Sarmiento Juan M, 2003, Surg Oncol Clin N Am, V12, P231, DOI 10.1016/S1055-3207(02)00076-5
[80]   Aggressive surgery improves long-term survival in neuroendocrine pancreatic tumors - An institutional experience [J].
Schurr, Paulus G. ;
Strate, Tim ;
Rese, Kim ;
Kaifi, Jussuf T. ;
Reichelt, Uta ;
Petri, Susanne ;
Kleinhans, Helge ;
Yekebas, Emre F. ;
Izbicki, Jakob R. .
ANNALS OF SURGERY, 2007, 245 (02) :273-281